ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IART Integra LifeSciences Holdings Corporation

25.60
0.75 (3.02%)
23 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Integra LifeSciences Holdings Corporation NASDAQ:IART NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.75 3.02% 25.60 24.93 26.24 25.61 24.60 24.79 622,946 22:30:00

Integra LifeSciences Continues to Make Progress on Its ESG Strategy

21/08/2024 9:15pm

GlobeNewswire Inc.


Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart


From Jul 2024 to Jan 2025

Click Here for more Integra LifeSciences Charts.

Integra LifeSciences Holding Company (NASDAQ: IART), a leading global medical technology company, today issued its latest Environmental, Social and Governance (ESG) report. The report highlights the company’s 2023 ESG performance and ongoing efforts against the ESG strategy and roadmap established three years ago.

“Innovating treatment pathways to advance patient outcomes and set new standards of care is work that matters to our Integra colleagues around the world and is what drives us each and every day,” said Jan De Witte, president and chief executive officer, Integra LifeSciences. “We are pleased with the advances we have made to meet our ESG commitments and ambitions as we play our part to create healthier people, a healthier workplace and a healthier world.”

Integra’s ESG report includes the past year’s highlights in key areas:

  • Environmental – Recalculated Scope 1, 2 and 3 emissions and partnered with an external consultant to conduct energy assessments at highest energy usage locations to identify energy reduction opportunities and improve greenhouse gas footprint
  • Social – Bolstered diversity and inclusion efforts by adding a new employee resource group and furthering our focus on early-in-career talent by providing support and hands-on experience to diverse college students and graduates
  • Governance – Revised Code of Conduct and continued to strengthen anti-bribery and corruption program through ongoing training curriculums and programs

Integra prepared its ESG report in alignment with external guidelines and measurement frameworks, including the Global Reporting Index and the Sustainability Accounting Standards Board Index.

Read the full report here.

About Integra

At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit investor.integralife.com.

Contacts:

Investors: Chris Ward (609) 936-2322 chris.ward@integralife.com

Media: Laurene Isip (609) 208-8121 laurene.isip@integralife.com

1 Year Integra LifeSciences Chart

1 Year Integra LifeSciences Chart

1 Month Integra LifeSciences Chart

1 Month Integra LifeSciences Chart

Your Recent History

Delayed Upgrade Clock